@article{e6cf8af13c9744e485bffb09c74dc496,
title = "Life-threatening bronchiolitis in children: eight decades of critical care",
author = "Bem, \{Reinout A.\} and Bont, \{Louis J.\} and \{van Woensel\}, \{Job B.M.\}",
note = "Funding Information: Amsterdam University Medical Centers have received minor funding from AbbVie for invited lectures by RAB and JBMvW, who declare no competing interests. The University Medical Center Utrecht has received major funding for investigator-initiated studies from AbbVie, MedImmune, Janssen, the Bill and Melinda Gates Foundation, Nutricia (Danone), and MeMed Diagnostics; major cash or in-kind funding as part of the public–private partnership Innovative Medicines Initiative RESCEU project from GSK, Novavax, Janssen, AstraZeneca, Pfizer, and Sanofi; major funding from Julius Clinical for participating in the INFORM study sponsored by MedImmune; minor funding for participation in trials by Regeneron and Janssen from 2015 to 2017; and minor funding from AbbVie, MedImmune, Ablynx, Bavaria Nordic, MabXience, Novavax, Pfizer, and Janssen for consultation and invited lectures by LJB. LJB is the founding chairman of the ReSViNET Foundation; he has not received personal fees or other personal benefits from pharmaceutical companies or other industrial partners.",
year = "2020",
month = feb,
doi = "10.1016/S2213-2600(19)30445-X",
language = "English",
volume = "8",
pages = "142--144",
journal = "The Lancet Respiratory Medicine",
issn = "2213-2600",
publisher = "Elsevier Ltd.",
number = "2",
}